Priti Hegde - Net Worth and Insider Trading

Priti Hegde Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Priti Hegde owns 2 companies in total, including TCR2 Therapeutics Inc (TCRR) , and Adaptimmune Therapeutics PLC (ADAP) .

Click here to see the complete history of Priti Hegde’s form 4 insider trades.

Insider Ownership Summary of Priti Hegde

Ticker	Comapny	Transaction Date	Type of Owner
TCRR	TCR2 Therapeutics Inc	2022-12-15	director
ADAP	Adaptimmune Therapeutics PLC	2023-06-01	director

Priti Hegde Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Priti Hegde Ownership Network

Ownership Network List of Priti Hegde

No Data

Ownership Network Relation of Priti Hegde

Priti Hegde Owned Company Details

What does TCR2 Therapeutics Inc do?

Who are the key executives at TCR2 Therapeutics Inc?

Priti Hegde is the director of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin C Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .

TCR2 Therapeutics Inc (TCRR) Insider Trades Summary

Over the past 18 months, Priti Hegde made no insider transaction in TCR2 Therapeutics Inc (TCRR). Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net purchase of 94,948 shares made by Kevin C Tang , a net sale of 70,170 shares made by Ansbert Gadicke , and a net sale of 70,170 shares made by Mpm Asset Management Llc .

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 140,340 shares of TCR2 Therapeutics Inc (TCRR) were sold and 94,948 shares were bought by its insiders, resulting in a net sale of 45,392 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

TCR2 Therapeutics Inc Insider Transactions

No Available Data

Priti Hegde Mailing Address

Above is the net worth, insider trading, and ownership report for Priti Hegde. You might contact Priti Hegde via mailing address: Tcr2 Therapeutics Inc., 100 Binney Street, Suite 710, Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.